COVID-19 Impact on Global Neuroprotective Agents Market Insights, Forecast to 2026
Neuroprotective agents are medications that can alter the course of metabolic events after the onset of ischemia and therefore have the potential to reduce stroke damage.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Neuroprotective Agents market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Neuroprotective Agents industry.
Based on our recent survey, we have several different scenarios about the Neuroprotective Agents YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Neuroprotective Agents will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuroprotective Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuroprotective Agents market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Neuroprotective Agents market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Neuroprotective Agents market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Neuroprotective Agents market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Neuroprotective Agents market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuroprotective Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuroprotective Agents market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Neuroprotective Agents market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Neuroprotective Agents industry.
Based on our recent survey, we have several different scenarios about the Neuroprotective Agents YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Neuroprotective Agents will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuroprotective Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuroprotective Agents market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Neuroprotective Agents market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Neuroprotective Agents market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Neuroprotective Agents market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Neuroprotective Agents market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuroprotective Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuroprotective Agents market.
The following manufacturers are covered in this report:
- Genervon Biopharmaceuticals
- NeuroVive Pharmaceutical
- Ceregene
- Neuren Pharmaceuticals
- Allon Therapeutics
- Cerebrovascular Diseases
- Neurodegenerative Disorders
- Ophthalmic Diseases
- Traumatic CNS Injuries
- Hospitals
- Clinics
- Others
1 STUDY COVERAGE
1.1 Neuroprotective Agents Product Introduction
1.2 Market Segments
1.3 Key Neuroprotective Agents Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Neuroprotective Agents Market Size Growth Rate by Type
1.4.2 Cerebrovascular Diseases
1.4.3 Neurodegenerative Disorders
1.4.4 Ophthalmic Diseases
1.4.5 Traumatic CNS Injuries
1.5 Market by Application
1.5.1 Global Neuroprotective Agents Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Neuroprotective Agents Industry Impact
1.6.1 How the Covid-19 is Affecting the Neuroprotective Agents Industry
1.6.1.1 Neuroprotective Agents Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Neuroprotective Agents Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Neuroprotective Agents Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Neuroprotective Agents Market Size Estimates and Forecasts
2.1.1 Global Neuroprotective Agents Revenue 2015-2026
2.1.2 Global Neuroprotective Agents Sales 2015-2026
2.2 Neuroprotective Agents Market Size by Region: 2020 Versus 2026
2.2.1 Global Neuroprotective Agents Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Neuroprotective Agents Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL NEUROPROTECTIVE AGENTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Neuroprotective Agents Sales by Manufacturers
3.1.1 Neuroprotective Agents Sales by Manufacturers (2015-2020)
3.1.2 Neuroprotective Agents Sales Market Share by Manufacturers (2015-2020)
3.2 Neuroprotective Agents Revenue by Manufacturers
3.2.1 Neuroprotective Agents Revenue by Manufacturers (2015-2020)
3.2.2 Neuroprotective Agents Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Neuroprotective Agents Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Neuroprotective Agents Revenue in 2019
3.2.5 Global Neuroprotective Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Neuroprotective Agents Price by Manufacturers
3.4 Neuroprotective Agents Manufacturing Base Distribution, Product Types
3.4.1 Neuroprotective Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neuroprotective Agents Product Type
3.4.3 Date of International Manufacturers Enter into Neuroprotective Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Neuroprotective Agents Market Size by Type (2015-2020)
4.1.1 Global Neuroprotective Agents Sales by Type (2015-2020)
4.1.2 Global Neuroprotective Agents Revenue by Type (2015-2020)
4.1.3 Neuroprotective Agents Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Neuroprotective Agents Market Size Forecast by Type (2021-2026)
4.2.1 Global Neuroprotective Agents Sales Forecast by Type (2021-2026)
4.2.2 Global Neuroprotective Agents Revenue Forecast by Type (2021-2026)
4.2.3 Neuroprotective Agents Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Neuroprotective Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Neuroprotective Agents Market Size by Application (2015-2020)
5.1.1 Global Neuroprotective Agents Sales by Application (2015-2020)
5.1.2 Global Neuroprotective Agents Revenue by Application (2015-2020)
5.1.3 Neuroprotective Agents Price by Application (2015-2020)
5.2 Neuroprotective Agents Market Size Forecast by Application (2021-2026)
5.2.1 Global Neuroprotective Agents Sales Forecast by Application (2021-2026)
5.2.2 Global Neuroprotective Agents Revenue Forecast by Application (2021-2026)
5.2.3 Global Neuroprotective Agents Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Neuroprotective Agents by Country
6.1.1 North America Neuroprotective Agents Sales by Country
6.1.2 North America Neuroprotective Agents Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Neuroprotective Agents Market Facts & Figures by Type
6.3 North America Neuroprotective Agents Market Facts & Figures by Application
7 EUROPE
7.1 Europe Neuroprotective Agents by Country
7.1.1 Europe Neuroprotective Agents Sales by Country
7.1.2 Europe Neuroprotective Agents Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neuroprotective Agents Market Facts & Figures by Type
7.3 Europe Neuroprotective Agents Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Neuroprotective Agents by Region
8.1.1 Asia Pacific Neuroprotective Agents Sales by Region
8.1.2 Asia Pacific Neuroprotective Agents Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Neuroprotective Agents Market Facts & Figures by Type
8.3 Asia Pacific Neuroprotective Agents Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Neuroprotective Agents by Country
9.1.1 Latin America Neuroprotective Agents Sales by Country
9.1.2 Latin America Neuroprotective Agents Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Neuroprotective Agents Market Facts & Figures by Type
9.3 Central & South America Neuroprotective Agents Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Neuroprotective Agents by Country
10.1.1 Middle East and Africa Neuroprotective Agents Sales by Country
10.1.2 Middle East and Africa Neuroprotective Agents Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Neuroprotective Agents Market Facts & Figures by Type
10.3 Middle East and Africa Neuroprotective Agents Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Genervon Biopharmaceuticals
11.1.1 Genervon Biopharmaceuticals Corporation Information
11.1.2 Genervon Biopharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Genervon Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genervon Biopharmaceuticals Neuroprotective Agents Products Offered
11.1.5 Genervon Biopharmaceuticals Recent Development
11.2 NeuroVive Pharmaceutical
11.2.1 NeuroVive Pharmaceutical Corporation Information
11.2.2 NeuroVive Pharmaceutical Description, Business Overview and Total Revenue
11.2.3 NeuroVive Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 NeuroVive Pharmaceutical Neuroprotective Agents Products Offered
11.2.5 NeuroVive Pharmaceutical Recent Development
11.3 Ceregene
11.3.1 Ceregene Corporation Information
11.3.2 Ceregene Description, Business Overview and Total Revenue
11.3.3 Ceregene Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Ceregene Neuroprotective Agents Products Offered
11.3.5 Ceregene Recent Development
11.4 Neuren Pharmaceuticals
11.4.1 Neuren Pharmaceuticals Corporation Information
11.4.2 Neuren Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Neuren Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Neuren Pharmaceuticals Neuroprotective Agents Products Offered
11.4.5 Neuren Pharmaceuticals Recent Development
11.5 Allon Therapeutics
11.5.1 Allon Therapeutics Corporation Information
11.5.2 Allon Therapeutics Description, Business Overview and Total Revenue
11.5.3 Allon Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Allon Therapeutics Neuroprotective Agents Products Offered
11.5.5 Allon Therapeutics Recent Development
11.1 Genervon Biopharmaceuticals
11.1.1 Genervon Biopharmaceuticals Corporation Information
11.1.2 Genervon Biopharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Genervon Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genervon Biopharmaceuticals Neuroprotective Agents Products Offered
11.1.5 Genervon Biopharmaceuticals Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Neuroprotective Agents Market Estimates and Projections by Region
12.1.1 Global Neuroprotective Agents Sales Forecast by Regions 2021-2026
12.1.2 Global Neuroprotective Agents Revenue Forecast by Regions 2021-2026
12.2 North America Neuroprotective Agents Market Size Forecast (2021-2026)
12.2.1 North America: Neuroprotective Agents Sales Forecast (2021-2026)
12.2.2 North America: Neuroprotective Agents Revenue Forecast (2021-2026)
12.2.3 North America: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
12.3 Europe Neuroprotective Agents Market Size Forecast (2021-2026)
12.3.1 Europe: Neuroprotective Agents Sales Forecast (2021-2026)
12.3.2 Europe: Neuroprotective Agents Revenue Forecast (2021-2026)
12.3.3 Europe: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Neuroprotective Agents Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Neuroprotective Agents Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Neuroprotective Agents Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Neuroprotective Agents Market Size Forecast by Region (2021-2026)
12.5 Latin America Neuroprotective Agents Market Size Forecast (2021-2026)
12.5.1 Latin America: Neuroprotective Agents Sales Forecast (2021-2026)
12.5.2 Latin America: Neuroprotective Agents Revenue Forecast (2021-2026)
12.5.3 Latin America: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Neuroprotective Agents Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Neuroprotective Agents Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Neuroprotective Agents Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Neuroprotective Agents Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Neuroprotective Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Neuroprotective Agents Product Introduction
1.2 Market Segments
1.3 Key Neuroprotective Agents Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Neuroprotective Agents Market Size Growth Rate by Type
1.4.2 Cerebrovascular Diseases
1.4.3 Neurodegenerative Disorders
1.4.4 Ophthalmic Diseases
1.4.5 Traumatic CNS Injuries
1.5 Market by Application
1.5.1 Global Neuroprotective Agents Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Neuroprotective Agents Industry Impact
1.6.1 How the Covid-19 is Affecting the Neuroprotective Agents Industry
1.6.1.1 Neuroprotective Agents Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Neuroprotective Agents Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Neuroprotective Agents Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Neuroprotective Agents Market Size Estimates and Forecasts
2.1.1 Global Neuroprotective Agents Revenue 2015-2026
2.1.2 Global Neuroprotective Agents Sales 2015-2026
2.2 Neuroprotective Agents Market Size by Region: 2020 Versus 2026
2.2.1 Global Neuroprotective Agents Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Neuroprotective Agents Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL NEUROPROTECTIVE AGENTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Neuroprotective Agents Sales by Manufacturers
3.1.1 Neuroprotective Agents Sales by Manufacturers (2015-2020)
3.1.2 Neuroprotective Agents Sales Market Share by Manufacturers (2015-2020)
3.2 Neuroprotective Agents Revenue by Manufacturers
3.2.1 Neuroprotective Agents Revenue by Manufacturers (2015-2020)
3.2.2 Neuroprotective Agents Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Neuroprotective Agents Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Neuroprotective Agents Revenue in 2019
3.2.5 Global Neuroprotective Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Neuroprotective Agents Price by Manufacturers
3.4 Neuroprotective Agents Manufacturing Base Distribution, Product Types
3.4.1 Neuroprotective Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neuroprotective Agents Product Type
3.4.3 Date of International Manufacturers Enter into Neuroprotective Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Neuroprotective Agents Market Size by Type (2015-2020)
4.1.1 Global Neuroprotective Agents Sales by Type (2015-2020)
4.1.2 Global Neuroprotective Agents Revenue by Type (2015-2020)
4.1.3 Neuroprotective Agents Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Neuroprotective Agents Market Size Forecast by Type (2021-2026)
4.2.1 Global Neuroprotective Agents Sales Forecast by Type (2021-2026)
4.2.2 Global Neuroprotective Agents Revenue Forecast by Type (2021-2026)
4.2.3 Neuroprotective Agents Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Neuroprotective Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Neuroprotective Agents Market Size by Application (2015-2020)
5.1.1 Global Neuroprotective Agents Sales by Application (2015-2020)
5.1.2 Global Neuroprotective Agents Revenue by Application (2015-2020)
5.1.3 Neuroprotective Agents Price by Application (2015-2020)
5.2 Neuroprotective Agents Market Size Forecast by Application (2021-2026)
5.2.1 Global Neuroprotective Agents Sales Forecast by Application (2021-2026)
5.2.2 Global Neuroprotective Agents Revenue Forecast by Application (2021-2026)
5.2.3 Global Neuroprotective Agents Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Neuroprotective Agents by Country
6.1.1 North America Neuroprotective Agents Sales by Country
6.1.2 North America Neuroprotective Agents Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Neuroprotective Agents Market Facts & Figures by Type
6.3 North America Neuroprotective Agents Market Facts & Figures by Application
7 EUROPE
7.1 Europe Neuroprotective Agents by Country
7.1.1 Europe Neuroprotective Agents Sales by Country
7.1.2 Europe Neuroprotective Agents Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neuroprotective Agents Market Facts & Figures by Type
7.3 Europe Neuroprotective Agents Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Neuroprotective Agents by Region
8.1.1 Asia Pacific Neuroprotective Agents Sales by Region
8.1.2 Asia Pacific Neuroprotective Agents Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Neuroprotective Agents Market Facts & Figures by Type
8.3 Asia Pacific Neuroprotective Agents Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Neuroprotective Agents by Country
9.1.1 Latin America Neuroprotective Agents Sales by Country
9.1.2 Latin America Neuroprotective Agents Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Neuroprotective Agents Market Facts & Figures by Type
9.3 Central & South America Neuroprotective Agents Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Neuroprotective Agents by Country
10.1.1 Middle East and Africa Neuroprotective Agents Sales by Country
10.1.2 Middle East and Africa Neuroprotective Agents Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Neuroprotective Agents Market Facts & Figures by Type
10.3 Middle East and Africa Neuroprotective Agents Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Genervon Biopharmaceuticals
11.1.1 Genervon Biopharmaceuticals Corporation Information
11.1.2 Genervon Biopharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Genervon Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genervon Biopharmaceuticals Neuroprotective Agents Products Offered
11.1.5 Genervon Biopharmaceuticals Recent Development
11.2 NeuroVive Pharmaceutical
11.2.1 NeuroVive Pharmaceutical Corporation Information
11.2.2 NeuroVive Pharmaceutical Description, Business Overview and Total Revenue
11.2.3 NeuroVive Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 NeuroVive Pharmaceutical Neuroprotective Agents Products Offered
11.2.5 NeuroVive Pharmaceutical Recent Development
11.3 Ceregene
11.3.1 Ceregene Corporation Information
11.3.2 Ceregene Description, Business Overview and Total Revenue
11.3.3 Ceregene Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Ceregene Neuroprotective Agents Products Offered
11.3.5 Ceregene Recent Development
11.4 Neuren Pharmaceuticals
11.4.1 Neuren Pharmaceuticals Corporation Information
11.4.2 Neuren Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Neuren Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Neuren Pharmaceuticals Neuroprotective Agents Products Offered
11.4.5 Neuren Pharmaceuticals Recent Development
11.5 Allon Therapeutics
11.5.1 Allon Therapeutics Corporation Information
11.5.2 Allon Therapeutics Description, Business Overview and Total Revenue
11.5.3 Allon Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Allon Therapeutics Neuroprotective Agents Products Offered
11.5.5 Allon Therapeutics Recent Development
11.1 Genervon Biopharmaceuticals
11.1.1 Genervon Biopharmaceuticals Corporation Information
11.1.2 Genervon Biopharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Genervon Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genervon Biopharmaceuticals Neuroprotective Agents Products Offered
11.1.5 Genervon Biopharmaceuticals Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Neuroprotective Agents Market Estimates and Projections by Region
12.1.1 Global Neuroprotective Agents Sales Forecast by Regions 2021-2026
12.1.2 Global Neuroprotective Agents Revenue Forecast by Regions 2021-2026
12.2 North America Neuroprotective Agents Market Size Forecast (2021-2026)
12.2.1 North America: Neuroprotective Agents Sales Forecast (2021-2026)
12.2.2 North America: Neuroprotective Agents Revenue Forecast (2021-2026)
12.2.3 North America: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
12.3 Europe Neuroprotective Agents Market Size Forecast (2021-2026)
12.3.1 Europe: Neuroprotective Agents Sales Forecast (2021-2026)
12.3.2 Europe: Neuroprotective Agents Revenue Forecast (2021-2026)
12.3.3 Europe: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Neuroprotective Agents Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Neuroprotective Agents Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Neuroprotective Agents Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Neuroprotective Agents Market Size Forecast by Region (2021-2026)
12.5 Latin America Neuroprotective Agents Market Size Forecast (2021-2026)
12.5.1 Latin America: Neuroprotective Agents Sales Forecast (2021-2026)
12.5.2 Latin America: Neuroprotective Agents Revenue Forecast (2021-2026)
12.5.3 Latin America: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Neuroprotective Agents Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Neuroprotective Agents Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Neuroprotective Agents Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Neuroprotective Agents Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Neuroprotective Agents Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Neuroprotective Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Neuroprotective Agents Market Segments
Table 2. Ranking of Global Top Neuroprotective Agents Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Neuroprotective Agents Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Cerebrovascular Diseases
Table 5. Major Manufacturers of Neurodegenerative Disorders
Table 6. Major Manufacturers of Ophthalmic Diseases
Table 7. Major Manufacturers of Traumatic CNS Injuries
Table 8. COVID-19 Impact Global Market: (Four Neuroprotective Agents Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Neuroprotective Agents Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Neuroprotective Agents Players to Combat Covid-19 Impact
Table 13. Global Neuroprotective Agents Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Neuroprotective Agents Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Neuroprotective Agents Sales by Regions 2015-2020 (K MT)
Table 16. Global Neuroprotective Agents Sales Market Share by Regions (2015-2020)
Table 17. Global Neuroprotective Agents Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Neuroprotective Agents Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Neuroprotective Agents Sales Share by Manufacturers (2015-2020)
Table 20. Global Neuroprotective Agents Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Neuroprotective Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroprotective Agents as of 2019)
Table 22. Neuroprotective Agents Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Neuroprotective Agents Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Neuroprotective Agents Price (2015-2020) (USD/MT)
Table 25. Neuroprotective Agents Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Neuroprotective Agents Product Type
Table 27. Date of International Manufacturers Enter into Neuroprotective Agents Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 30. Global Neuroprotective Agents Sales Share by Type (2015-2020)
Table 31. Global Neuroprotective Agents Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Neuroprotective Agents Revenue Share by Type (2015-2020)
Table 33. Neuroprotective Agents Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 35. Global Neuroprotective Agents Sales Share by Application (2015-2020)
Table 36. North America Neuroprotective Agents Sales by Country (2015-2020) (K MT)
Table 37. North America Neuroprotective Agents Sales Market Share by Country (2015-2020)
Table 38. North America Neuroprotective Agents Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Neuroprotective Agents Revenue Market Share by Country (2015-2020)
Table 40. North America Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 41. North America Neuroprotective Agents Sales Market Share by Type (2015-2020)
Table 42. North America Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 43. North America Neuroprotective Agents Sales Market Share by Application (2015-2020)
Table 44. Europe Neuroprotective Agents Sales by Country (2015-2020) (K MT)
Table 45. Europe Neuroprotective Agents Sales Market Share by Country (2015-2020)
Table 46. Europe Neuroprotective Agents Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Neuroprotective Agents Revenue Market Share by Country (2015-2020)
Table 48. Europe Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 49. Europe Neuroprotective Agents Sales Market Share by Type (2015-2020)
Table 50. Europe Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 51. Europe Neuroprotective Agents Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Neuroprotective Agents Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Neuroprotective Agents Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Neuroprotective Agents Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Neuroprotective Agents Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Neuroprotective Agents Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Neuroprotective Agents Sales Market Share by Application (2015-2020)
Table 60. Latin America Neuroprotective Agents Sales by Country (2015-2020) (K MT)
Table 61. Latin America Neuroprotective Agents Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Neuroprotective Agents Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Neuroprotective Agents Revenue Market Share by Country (2015-2020)
Table 64. Latin America Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 65. Latin America Neuroprotective Agents Sales Market Share by Type (2015-2020)
Table 66. Latin America Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 67. Latin America Neuroprotective Agents Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Neuroprotective Agents Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Neuroprotective Agents Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Neuroprotective Agents Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Neuroprotective Agents Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Neuroprotective Agents Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Neuroprotective Agents Sales Market Share by Application (2015-2020)
Table 76. Genervon Biopharmaceuticals Corporation Information
Table 77. Genervon Biopharmaceuticals Description and Major Businesses
Table 78. Genervon Biopharmaceuticals Neuroprotective Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Genervon Biopharmaceuticals Product
Table 80. Genervon Biopharmaceuticals Recent Development
Table 81. NeuroVive Pharmaceutical Corporation Information
Table 82. NeuroVive Pharmaceutical Description and Major Businesses
Table 83. NeuroVive Pharmaceutical Neuroprotective Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. NeuroVive Pharmaceutical Product
Table 85. NeuroVive Pharmaceutical Recent Development
Table 86. Ceregene Corporation Information
Table 87. Ceregene Description and Major Businesses
Table 88. Ceregene Neuroprotective Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Ceregene Product
Table 90. Ceregene Recent Development
Table 91. Neuren Pharmaceuticals Corporation Information
Table 92. Neuren Pharmaceuticals Description and Major Businesses
Table 93. Neuren Pharmaceuticals Neuroprotective Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Neuren Pharmaceuticals Product
Table 95. Neuren Pharmaceuticals Recent Development
Table 96. Allon Therapeutics Corporation Information
Table 97. Allon Therapeutics Description and Major Businesses
Table 98. Allon Therapeutics Neuroprotective Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Allon Therapeutics Product
Table 100. Allon Therapeutics Recent Development
Table 101. Global Neuroprotective Agents Sales Forecast by Regions (2021-2026) (K MT)
Table 102. Global Neuroprotective Agents Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Neuroprotective Agents Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Neuroprotective Agents Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Neuroprotective Agents Sales Forecast by Country (2021-2026) (K MT)
Table 106. North America: Neuroprotective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Neuroprotective Agents Sales Forecast by Country (2021-2026) (K MT)
Table 108. Europe: Neuroprotective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Neuroprotective Agents Sales Forecast by Region (2021-2026) (K MT)
Table 110. Asia Pacific: Neuroprotective Agents Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Neuroprotective Agents Sales Forecast by Country (2021-2026) (K MT)
Table 112. Latin America: Neuroprotective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Neuroprotective Agents Sales Forecast by Country (2021-2026) (K MT)
Table 114. Middle East and Africa: Neuroprotective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Neuroprotective Agents Players
Table 119. Neuroprotective Agents Customers List
Table 120. Neuroprotective Agents Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 1. Neuroprotective Agents Market Segments
Table 2. Ranking of Global Top Neuroprotective Agents Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Neuroprotective Agents Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Cerebrovascular Diseases
Table 5. Major Manufacturers of Neurodegenerative Disorders
Table 6. Major Manufacturers of Ophthalmic Diseases
Table 7. Major Manufacturers of Traumatic CNS Injuries
Table 8. COVID-19 Impact Global Market: (Four Neuroprotective Agents Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Neuroprotective Agents Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Neuroprotective Agents Players to Combat Covid-19 Impact
Table 13. Global Neuroprotective Agents Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Neuroprotective Agents Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Neuroprotective Agents Sales by Regions 2015-2020 (K MT)
Table 16. Global Neuroprotective Agents Sales Market Share by Regions (2015-2020)
Table 17. Global Neuroprotective Agents Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Neuroprotective Agents Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Neuroprotective Agents Sales Share by Manufacturers (2015-2020)
Table 20. Global Neuroprotective Agents Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Neuroprotective Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroprotective Agents as of 2019)
Table 22. Neuroprotective Agents Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Neuroprotective Agents Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Neuroprotective Agents Price (2015-2020) (USD/MT)
Table 25. Neuroprotective Agents Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Neuroprotective Agents Product Type
Table 27. Date of International Manufacturers Enter into Neuroprotective Agents Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 30. Global Neuroprotective Agents Sales Share by Type (2015-2020)
Table 31. Global Neuroprotective Agents Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Neuroprotective Agents Revenue Share by Type (2015-2020)
Table 33. Neuroprotective Agents Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 35. Global Neuroprotective Agents Sales Share by Application (2015-2020)
Table 36. North America Neuroprotective Agents Sales by Country (2015-2020) (K MT)
Table 37. North America Neuroprotective Agents Sales Market Share by Country (2015-2020)
Table 38. North America Neuroprotective Agents Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Neuroprotective Agents Revenue Market Share by Country (2015-2020)
Table 40. North America Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 41. North America Neuroprotective Agents Sales Market Share by Type (2015-2020)
Table 42. North America Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 43. North America Neuroprotective Agents Sales Market Share by Application (2015-2020)
Table 44. Europe Neuroprotective Agents Sales by Country (2015-2020) (K MT)
Table 45. Europe Neuroprotective Agents Sales Market Share by Country (2015-2020)
Table 46. Europe Neuroprotective Agents Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Neuroprotective Agents Revenue Market Share by Country (2015-2020)
Table 48. Europe Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 49. Europe Neuroprotective Agents Sales Market Share by Type (2015-2020)
Table 50. Europe Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 51. Europe Neuroprotective Agents Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Neuroprotective Agents Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Neuroprotective Agents Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Neuroprotective Agents Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Neuroprotective Agents Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Neuroprotective Agents Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Neuroprotective Agents Sales Market Share by Application (2015-2020)
Table 60. Latin America Neuroprotective Agents Sales by Country (2015-2020) (K MT)
Table 61. Latin America Neuroprotective Agents Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Neuroprotective Agents Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Neuroprotective Agents Revenue Market Share by Country (2015-2020)
Table 64. Latin America Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 65. Latin America Neuroprotective Agents Sales Market Share by Type (2015-2020)
Table 66. Latin America Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 67. Latin America Neuroprotective Agents Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Neuroprotective Agents Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Neuroprotective Agents Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Neuroprotective Agents Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Neuroprotective Agents Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Neuroprotective Agents Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Neuroprotective Agents Sales Market Share by Application (2015-2020)
Table 76. Genervon Biopharmaceuticals Corporation Information
Table 77. Genervon Biopharmaceuticals Description and Major Businesses
Table 78. Genervon Biopharmaceuticals Neuroprotective Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Genervon Biopharmaceuticals Product
Table 80. Genervon Biopharmaceuticals Recent Development
Table 81. NeuroVive Pharmaceutical Corporation Information
Table 82. NeuroVive Pharmaceutical Description and Major Businesses
Table 83. NeuroVive Pharmaceutical Neuroprotective Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. NeuroVive Pharmaceutical Product
Table 85. NeuroVive Pharmaceutical Recent Development
Table 86. Ceregene Corporation Information
Table 87. Ceregene Description and Major Businesses
Table 88. Ceregene Neuroprotective Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Ceregene Product
Table 90. Ceregene Recent Development
Table 91. Neuren Pharmaceuticals Corporation Information
Table 92. Neuren Pharmaceuticals Description and Major Businesses
Table 93. Neuren Pharmaceuticals Neuroprotective Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Neuren Pharmaceuticals Product
Table 95. Neuren Pharmaceuticals Recent Development
Table 96. Allon Therapeutics Corporation Information
Table 97. Allon Therapeutics Description and Major Businesses
Table 98. Allon Therapeutics Neuroprotective Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Allon Therapeutics Product
Table 100. Allon Therapeutics Recent Development
Table 101. Global Neuroprotective Agents Sales Forecast by Regions (2021-2026) (K MT)
Table 102. Global Neuroprotective Agents Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Neuroprotective Agents Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Neuroprotective Agents Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Neuroprotective Agents Sales Forecast by Country (2021-2026) (K MT)
Table 106. North America: Neuroprotective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Neuroprotective Agents Sales Forecast by Country (2021-2026) (K MT)
Table 108. Europe: Neuroprotective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Neuroprotective Agents Sales Forecast by Region (2021-2026) (K MT)
Table 110. Asia Pacific: Neuroprotective Agents Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Neuroprotective Agents Sales Forecast by Country (2021-2026) (K MT)
Table 112. Latin America: Neuroprotective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Neuroprotective Agents Sales Forecast by Country (2021-2026) (K MT)
Table 114. Middle East and Africa: Neuroprotective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Neuroprotective Agents Players
Table 119. Neuroprotective Agents Customers List
Table 120. Neuroprotective Agents Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Neuroprotective Agents Product Picture
Figure 2. Global Neuroprotective Agents Sales Market Share by Type in 2020 & 2026
Figure 3. Cerebrovascular Diseases Product Picture
Figure 4. Neurodegenerative Disorders Product Picture
Figure 5. Ophthalmic Diseases Product Picture
Figure 6. Traumatic CNS Injuries Product Picture
Figure 7. Global Neuroprotective Agents Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Neuroprotective Agents Report Years Considered
Figure 12. Global Neuroprotective Agents Market Size 2015-2026 (US$ Million)
Figure 13. Global Neuroprotective Agents Sales 2015-2026 (K MT)
Figure 14. Global Neuroprotective Agents Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Neuroprotective Agents Sales Market Share by Region (2015-2020)
Figure 16. Global Neuroprotective Agents Sales Market Share by Region in 2019
Figure 17. Global Neuroprotective Agents Revenue Market Share by Region (2015-2020)
Figure 18. Global Neuroprotective Agents Revenue Market Share by Region in 2019
Figure 19. Global Neuroprotective Agents Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Neuroprotective Agents Revenue in 2019
Figure 21. Neuroprotective Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Neuroprotective Agents Sales Market Share by Type (2015-2020)
Figure 23. Global Neuroprotective Agents Sales Market Share by Type in 2019
Figure 24. Global Neuroprotective Agents Revenue Market Share by Type (2015-2020)
Figure 25. Global Neuroprotective Agents Revenue Market Share by Type in 2019
Figure 26. Global Neuroprotective Agents Market Share by Price Range (2015-2020)
Figure 27. Global Neuroprotective Agents Sales Market Share by Application (2015-2020)
Figure 28. Global Neuroprotective Agents Sales Market Share by Application in 2019
Figure 29. Global Neuroprotective Agents Revenue Market Share by Application (2015-2020)
Figure 30. Global Neuroprotective Agents Revenue Market Share by Application in 2019
Figure 31. North America Neuroprotective Agents Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Neuroprotective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Neuroprotective Agents Sales Market Share by Country in 2019
Figure 34. North America Neuroprotective Agents Revenue Market Share by Country in 2019
Figure 35. U.S. Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Neuroprotective Agents Market Share by Type in 2019
Figure 40. North America Neuroprotective Agents Market Share by Application in 2019
Figure 41. Europe Neuroprotective Agents Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Neuroprotective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Neuroprotective Agents Sales Market Share by Country in 2019
Figure 44. Europe Neuroprotective Agents Revenue Market Share by Country in 2019
Figure 45. Germany Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Neuroprotective Agents Market Share by Type in 2019
Figure 56. Europe Neuroprotective Agents Market Share by Application in 2019
Figure 57. Asia Pacific Neuroprotective Agents Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Neuroprotective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Neuroprotective Agents Sales Market Share by Region in 2019
Figure 60. Asia Pacific Neuroprotective Agents Revenue Market Share by Region in 2019
Figure 61. China Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Neuroprotective Agents Market Share by Type in 2019
Figure 84. Asia Pacific Neuroprotective Agents Market Share by Application in 2019
Figure 85. Latin America Neuroprotective Agents Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Neuroprotective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Neuroprotective Agents Sales Market Share by Country in 2019
Figure 88. Latin America Neuroprotective Agents Revenue Market Share by Country in 2019
Figure 89. Mexico Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Neuroprotective Agents Market Share by Type in 2019
Figure 96. Latin America Neuroprotective Agents Market Share by Application in 2019
Figure 97. Middle East and Africa Neuroprotective Agents Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Neuroprotective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Neuroprotective Agents Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Neuroprotective Agents Revenue Market Share by Country in 2019
Figure 101. Turkey Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Neuroprotective Agents Market Share by Type in 2019
Figure 108. Middle East and Africa Neuroprotective Agents Market Share by Application in 2019
Figure 109. Genervon Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. NeuroVive Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Ceregene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Neuren Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Allon Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Neuroprotective Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. North America Neuroprotective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Neuroprotective Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Europe Neuroprotective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Neuroprotective Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Asia Pacific Neuroprotective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Neuroprotective Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Latin America Neuroprotective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Neuroprotective Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Middle East and Africa Neuroprotective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
Figure 1. Neuroprotective Agents Product Picture
Figure 2. Global Neuroprotective Agents Sales Market Share by Type in 2020 & 2026
Figure 3. Cerebrovascular Diseases Product Picture
Figure 4. Neurodegenerative Disorders Product Picture
Figure 5. Ophthalmic Diseases Product Picture
Figure 6. Traumatic CNS Injuries Product Picture
Figure 7. Global Neuroprotective Agents Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Neuroprotective Agents Report Years Considered
Figure 12. Global Neuroprotective Agents Market Size 2015-2026 (US$ Million)
Figure 13. Global Neuroprotective Agents Sales 2015-2026 (K MT)
Figure 14. Global Neuroprotective Agents Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Neuroprotective Agents Sales Market Share by Region (2015-2020)
Figure 16. Global Neuroprotective Agents Sales Market Share by Region in 2019
Figure 17. Global Neuroprotective Agents Revenue Market Share by Region (2015-2020)
Figure 18. Global Neuroprotective Agents Revenue Market Share by Region in 2019
Figure 19. Global Neuroprotective Agents Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Neuroprotective Agents Revenue in 2019
Figure 21. Neuroprotective Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Neuroprotective Agents Sales Market Share by Type (2015-2020)
Figure 23. Global Neuroprotective Agents Sales Market Share by Type in 2019
Figure 24. Global Neuroprotective Agents Revenue Market Share by Type (2015-2020)
Figure 25. Global Neuroprotective Agents Revenue Market Share by Type in 2019
Figure 26. Global Neuroprotective Agents Market Share by Price Range (2015-2020)
Figure 27. Global Neuroprotective Agents Sales Market Share by Application (2015-2020)
Figure 28. Global Neuroprotective Agents Sales Market Share by Application in 2019
Figure 29. Global Neuroprotective Agents Revenue Market Share by Application (2015-2020)
Figure 30. Global Neuroprotective Agents Revenue Market Share by Application in 2019
Figure 31. North America Neuroprotective Agents Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Neuroprotective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Neuroprotective Agents Sales Market Share by Country in 2019
Figure 34. North America Neuroprotective Agents Revenue Market Share by Country in 2019
Figure 35. U.S. Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Neuroprotective Agents Market Share by Type in 2019
Figure 40. North America Neuroprotective Agents Market Share by Application in 2019
Figure 41. Europe Neuroprotective Agents Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Neuroprotective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Neuroprotective Agents Sales Market Share by Country in 2019
Figure 44. Europe Neuroprotective Agents Revenue Market Share by Country in 2019
Figure 45. Germany Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Neuroprotective Agents Market Share by Type in 2019
Figure 56. Europe Neuroprotective Agents Market Share by Application in 2019
Figure 57. Asia Pacific Neuroprotective Agents Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Neuroprotective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Neuroprotective Agents Sales Market Share by Region in 2019
Figure 60. Asia Pacific Neuroprotective Agents Revenue Market Share by Region in 2019
Figure 61. China Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Neuroprotective Agents Market Share by Type in 2019
Figure 84. Asia Pacific Neuroprotective Agents Market Share by Application in 2019
Figure 85. Latin America Neuroprotective Agents Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Neuroprotective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Neuroprotective Agents Sales Market Share by Country in 2019
Figure 88. Latin America Neuroprotective Agents Revenue Market Share by Country in 2019
Figure 89. Mexico Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Neuroprotective Agents Market Share by Type in 2019
Figure 96. Latin America Neuroprotective Agents Market Share by Application in 2019
Figure 97. Middle East and Africa Neuroprotective Agents Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Neuroprotective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Neuroprotective Agents Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Neuroprotective Agents Revenue Market Share by Country in 2019
Figure 101. Turkey Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Neuroprotective Agents Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Neuroprotective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Neuroprotective Agents Market Share by Type in 2019
Figure 108. Middle East and Africa Neuroprotective Agents Market Share by Application in 2019
Figure 109. Genervon Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. NeuroVive Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Ceregene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Neuren Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Allon Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Neuroprotective Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. North America Neuroprotective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Neuroprotective Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Europe Neuroprotective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Neuroprotective Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Asia Pacific Neuroprotective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Neuroprotective Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Latin America Neuroprotective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Neuroprotective Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Middle East and Africa Neuroprotective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
